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Abstract: In familial hypercholesterolemia (FH) the level of LDL cholesterol is 2–3 times that 
of the normal population and leads to accelerated atherosclerosis. Improved care for risk factors 
has decreased cardiovascular mortality of these patients. We studied subclinical atherosclerotic 
changes with morphologic and functional aortic magnetic resonance imaging (MRI) in FH 
patients under the age of 50. 39 DNA test-veriﬁ  ed heterozygous FH-North Karelia patients, 
aged 6–48, 28 of them treated with statins, and 25 healthy controls, aged 12 to 50, underwent 
aortic MRI, carotid ultrasound (US), and risk-factor assessment. No differences in any of the 
morphologic or functional aortic parameters appeared between patients and controls. Age and 
gender were independent predictors of the majority of the morphologic and functional measures. 
Carotid intima-media thickness assessed by US was greater in patients (0.57 mm ± 0.13 vs 
0.48 ± 0.13 mm, p = 0.005) as was cholesterol-years score (243 ± 122 vs 137 ± 74, p  0.001). 
Patients had thicker intima-media of the common carotid artery and higher cholesterol burden 
as indicated by their cholesterol-years score. Despite this, no differences existed in morpho-
logic or functional aortic parameters assessed with MRI. The improved care of cardiovascular 
risk factors, especially statin treatment, may protect the aorta of FH patients. However, larger 
conﬁ  rmatory studies are needed.
Keywords: MRI, ultrasound, atherosclerosis, aorta, familial hypercholesterolemia
Introduction
Familial hypercholesterolemia (FH) is a hereditary disease caused by a low-density 
lipoprotein (LDL) receptor defect, which results in impaired cholesterol uptake in 
the liver (Goldstein and Hobbs 2001). The heterozygous form of the disease leads 
to 2- to 3-fold higher blood cholesterol levels from birth compared with those of the 
normal population, which results in accelerated atherosclerosis. The prevalence of 
heterozygous FH is 1/500. Atherosclerotic lesions of FH patients decrease with statin 
treatment (Smilde et al 2001), but patients still have higher (cardiovascular) mortal-
ity than does the normal population (Anonymous 1999). In the early 1990s the mean 
age of onset of coronary heart disease (CHD) was 42 and 48 years respectively for 
Finnish male and female FH patients with the North Karelia (FH-NK) mutation. Thirty 
percent of the patients over age 25 had CHD (Vuorio et al 1997). In contrast, in year 
2000 the combined prevalence for acute myocardial infarction and angina pectoris in 
the 30- to 64-year-old general Finnish population was 3.8 % and 1.3% for men and 
women, respectively (Reunanen et al 2004).
In atherosclerosis inﬂ  ammation, accumulating lipids and ﬁ  brosis change arterial 
morphology and elastic properties. The morphology in vascular MRI correlates well Vascular Health and Risk Management 2008:4(4) 924
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with histology (Clarke et al 2003) and elastic properties 
can be measured by magnetic resonance imaging (MRI) 
(Oliver and Webb 2003). A positive association exists in 
autopsy material between aortic and coronary atherosclerosis 
(Sternby 1968). Atherosclerotic lesions can be detected and 
characterized with MRI (Yuan and Kerwin 2004). In the 
1990s signs of subclinical atherosclerosis appeared in aortic 
MRI of 40% of clinically healthy people age 60, on average 
(Jaffer et al 2002).
The hypothesis of our study was, that despite the 
improved prognosis of FH patients due to developed risk 
factor treatment (statin treatment in particular), MRI of the 
aorta would reveal subclinical atherosclerosis. Our aim 
was to ﬁ  nd out if functional and morphological parameters 
of the aorta differ in young symptomless FH patients and 
normal controls. To assure the clinical relevance of the MRI 
results, we compared them with intima-media thickness 
(IMT) and strain of common carotid artery (CCA) assessed 
by ultrasound (US), and with cardiovascular risk factors 
(blood cholesterol levels, age, blood pressure, and body 
mass index: BMI).
Methods
Study participants
The province of North Karelia in Finland has approximately 
170,000 inhabitants and FH-NK mutation accounts for 
90% of its familial hypercholesterolemia cases (Koivisto 
et al 1992). During a 1-year-study period (year 2000) we 
invited all FH-NK patients under age 50 who had children 
and who were registered at the lipid clinic of our institu-
tion to take part in the study. Of the 60 FH-NK patients we 
found, 41, aged 6–48, agreed to participate. Two patients 
were excluded because one had a foreign metal body in the 
eye and the other was claustrophobic. The remaining 39 FH 
patients formed the patient group. One 45-year-old patient 
had had a myocardial infarction, and one 46-year-old patient 
had undergone coronary bypass surgery. The others had no 
history of diabetes, manifestations of atherosclerosis, or 
neurological disorders. No signs of intracranial alterations 
of vascular origin, including infarcts, appeared in their brain 
MRI (Soljanlahti et al 2005). Eleven patients did not receive 
statin medication, 9 because of their young age (less than 
16), 1 adult did not tolerate statin treatment, and 1 did not 
use statins regularly. Those 28 patients receiving medication 
were 27 years old on average at the beginning of statin treat-
ment. At the time of the examination they had, on average, 
been treated for 10 years.
The control group comprised 13 family members of the 
patients without the FH-NK mutation and 12 other Finn-
ish controls chosen among acquaintances of our radiology 
department staff. The controls were 12–50 years old with 
no history of diabetes, manifestations of atherosclerosis, or 
neurological disorders. One control was under 15 years of 
age. In total, 64 subjects, of whom 39 were FH-NK patients 
and 25 controls, took part (Table 1). The study was approved 
by the ethics committee and research board of our institution, 
with informed consent obtained from all subjects.
Aortic MRI
MRI was performed on a 1.5 T Siemens Vision imager 
(Erlangen, Germany) with a phased array coil; 23 axial 
images of the aorta starting from the top of the aortic arch 
were obtained with a T1-weighted, fat-saturated, turbo 
spin-echo (TSE) sequence (TR/TE/Flip Angle/FOV/Matrix/ 
Slice thickness = 2 RR/20ms/90°/200 × 200/128 × 256/6 mm) 
in free breathing. Then a breath hold oblique sagittal 
TSE sequence (TR/TE/ Flip Angle/FOV/Matrix/Slice 
Thickness = 700 ms/30 ms/180/400 × 300/130 × 256/7 mm) 
Table 1 Characteristics and risk factor levels of FH-NK patients and controls
 FH-NK  n  = 39  Controls n = 25  P value
Age, years  30.0 ± 13.6  30.6 ± 11.3  0.847
BMI, kg/m2 22.3  ± 4.1  23.0 ± 2.4  0.443
Systolic blood pressure, mmHg  120.9 ± 14.8  117.9 ± 11.2  0.402
Diastolic blood pressure, mmHg  70.5 ± 11.1  69.0 ± 9.8  0.580
Smokers, number  7  2  0.304
Total cholesterol, mmol/L  5.24 ± 1.70  3.89 ± 1.03  0.001
HDL cholesterol, mmol/L  1.13 ± 0.41  1.19 ± 0.30  0.282
LDL cholesterol, mmol/L  3.68 ± 1.41  2.27 ± 0.82  0.000
Triglycerides, mmol/L  0.94 ± 0.48  0.93 ± 0.32  0.736
Cholesterol-years, mmol-y/L  243 ± 122  137 ± 74  0.001
Values are mean (SD).
Abbreviations: FH, familial hypercholesterolemia-North Karelia; BMI, body mass index; HDL, high density lipoprotein; LDL, low density lipoprotein.Vascular Health and Risk Management 2008:4(4) 925
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was taken to assess the imaging plane on the level of the right 
pulmonary artery for the velocity-encoded ﬂ  ow-measurement 
sequence (TR/TE/Flip Angle/FOV/Matrix/Slice Thickness/
VENC = 26 ms/5 ms/30°/300 × 300/256 × 256/6 mm/150 
cm/s). ECG gating was used with all sequences.
The images were analyzed by 2 reviewers blinded to the 
clinical and laboratory data. Two morphologic (lumen and 
wall volume) and 2 functional measures (pulse wave velocity 
[PWV], and compliance) were assessed. The T1-weighted 
images starting from the ﬁ  rst slice below left arteria subclavia 
and ending at the last one above the celiac trunk were analyzed 
if they had sufﬁ  cient contrast to allow the visual deﬁ  nition 
of 50% of the circumference of the aortic wall. The subject 
was excluded from analysis if 50% of the slices did not 
meet these criteria. In total, the T1-TSE data of 53 subjects 
(30 patients and 23 controls) were analyzed. First, the boundar-
ies of the lumen and outer wall of the descending aorta were 
determined by manual tracing with MRIcro software (author: 
Chris Rorden, University of South Carolina, Columbia, SC, 
USA). The area of the lumen and wall on each slice was 
assessed and their volumes were calculated by multiplying the 
area by the sum of slice thickness (6 mm) and slice gap (6 mm). 
These volumes were added to provide the entire volume of the 
aortic wall and lumen. The values were adjusted by the body 
surface area (BSA) = [(height (cm) * weight (kg))/3600]½ of 
the patient. The velocity-encoded ﬂ  ow images were analyzed 
with NIH Image software (National Institutes of Health, 
Bethesda, MD, USA). The mean velocity of the blood ﬂ  ow in 
the ascending (AA) and descending aorta (DA) was assessed 
as a function of time. The temporal resolution was 26 ms. 
The pulse wave was considered to arrive when the velocity 
reached half of its maximum. From the velocity – time curves, 
the time delay of the pulse wave arrival between the ascending 
and descending aorta was measured. The distance between the 
two measurement sites was assessed from the oblique sagittal 
image as the mean of the distances along the inner and outer 
rims of the aorta. The PWV was calculated by dividing the 
distance by the delay in the pulse wave arrival between the 
measuring sites (Mohiaddin et al 1993). Compliance (%/
mmHg) was calculated from the anatomical set of ﬂ  ow images 
by the equation: [(Amax–Amin)/Amin*100]/(Ps–Pd), where 
Amax = maximum luminal area, Amin = minimal luminal 
area, Ps = systolic blood pressure, and Pd = diastolic blood 
pressure (Mohiaddin et al 1989).
Carotid US
All US examinations were performed with a Siemens Acuson 
128 XP/10 imager (Erlangen, Germany) and a 7 Mhz linear 
transducer by the same radiologist. Subjects were examined 
in supine position with the head turned slightly to the right. 
The IMT of the far wall of the left CCA was measured, in 
high-resolution B-mode (Pignoli et al 1986). The mean of 
3 consecutive measurements was calculated. CCA strain (%) 
was calculated by the equation: maximal diameter of CCA 
minus minimal diameter of CCA, and this was divided by 
the minimal diameter of CCA multiplied by 100 (Pearson 
et al 1996). The mean was calculated for 5 consecutive 
measurements.
Laboratory tests
After overnight fasting, each subject gave a venous blood 
sample. Serum total cholesterol, high-density lipoprotein 
(HDL) cholesterol, and triglycerides were determined by 
standard methods. The low-density lipoprotein (LDL) 
cholesterol value was calculated by the Friedewald formula 
(Friedewald et al 1972). To take into account the subjects’ 
lifelong cholesterol burden, we calculated the cholesterol-
years score, as suggested by Hoeg et al (1994). A DNA test 
(Koivisto et al 1993) was performed on all FH-NK patients 
and controls to detect the LDL receptor mutation. Blood 
pressure was measured twice from the left arm of each sub-
ject lying supine by means of an automatic Omega 1400™ 
meter (Invivo Research Inc, Orlando, FL, USA). The mean 
of 2 measurements was used in calculations.
Statistical methods
The means were compared with t-test or Mann-Whitney 
U-test, as appropriate. Categorial variables were compared 
with Fisher’s exact test. Correlations were calculated with 
Pearson’s or Spearman’s test. Multiple regression analysis 
was used to assess the factors best explaining changes in 
the functional and morphologic variables of the aorta. Age, 
gender, BMI, systolic RR, diastolic RR, LDL cholesterol, 
cholesterol-years score, and FH disease were included in 
the model. For lumen and wall volume measures, intraclass 
correlation coefﬁ  cient was assessed to evaluate inter rater 
reliability. The analyses were performed with NCSS 2000 
program (NCSS, Kaysville, UT, USA) and SPSS 13.0 (SPSS 
inc., Chicago, IL, USA). P value 0.05 was considered sta-
tistically signiﬁ  cant and used as a cut-off value in multiple 
regression analysis.
Results
No statistical difference appeared for any of the aortic mea-
sures (BSA-adjusted volume of the aortic lumen and wall, 
PWV, or the compliance of AA and DA) between FH-NK Vascular Health and Risk Management 2008:4(4) 926
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patients and controls (Table 2). Age, BMI, blood pressure, 
HDL cholesterol level, and cholesterol-years score correlated 
signiﬁ  cantly with almost all aortic measures (Table 3). The 
independent explaining factors for the variation in aortic 
measures assessed with multiple regression analysis were 
age or gender or both for all measures except for the compli-
ance of the DA (Table 4). All the aortic measures correlated 
signiﬁ  cantly with each other except compliance of the DA 
and volume of the aortic wall (Table 5). Intraclass correlation 
coefﬁ  cient was 0.979 and 0.523 for lumen and wall volume, 
respectively.
The mean IMT of the far wall of the CCA was sig-
niﬁ  cantly greater in the FH-NK patients than in the controls 
(Table 2). The strain of the CCA showed no signiﬁ  cant dif-
ference between patients and controls (Table 2). Signiﬁ  cant 
correlations appeared between carotid (IMT, CCA strain) 
and aortic measures except between IMT and compliance 
of DA (Table 5).
We found no statistical difference in BMI, blood pres-
sure, HDL cholesterol, or triglycerides between patients and 
controls (Table 1), while patients had higher total and LDL 
cholesterol levels and cholesterol-years score.
Discussion
We found no difference in the aortic MRI measures (BSA-
adjusted volume of the aortic lumen and wall, PWV, or 
the compliance) between the FH-NK patients and controls 
despite patients’ signiﬁ  cantly greater cholesterol-years score 
and carotid IMT. In the early 1990s when statin medication 
had been in use only for a short time, 30% of Finnish FH-
NK patients over age 25 had CHD (Vuorio et al 1997). In 
our study the lack of differences in aortic MRI between the 
groups may be due to the positive effect of improved risk fac-
tor treatment, statin medication in particular. Statin treatment 
induces regression of atherosclerotic lesions, which has been 
seen in MRI of aorta and carotid arteries (Corti et al 2002) 
and in US of carotid arteries (Smilde et al 2001).
In our study no difference existed between study groups 
in morphologic measurements of the aorta (volume of wall 
and lumen). Eleven percent regression of the aortic and 
carotid wall area was observed with MRI in 21 asymp-
tomatic hypercholesterolemic patients after 12 months of 
simvastatin therapy (Corti et al 2002). In another MRI study, 
18% regression of wall area of thoracic aorta was observed 
in 19 asymptomatic hypercholesterolemic patients after 
12 months of atorvastatin therapy (Yonemura et al 2005). 
Jaffer et al (2002) measured aortic wall area and found out 
that 38% of women and 41% of men free of clinically appar-
ent CHD (aged 36–78) had evidence of subclinical aortic 
atherosclerosis.
In our study the compliance in aortic MRI and strain of 
CCA observed with US showed that the arterial walls of the 
patients were more compliant (although not signiﬁ  cantly) 
than those of the controls. The aortic PWV, however, showed 
no difference between the groups. Earlier MRI studies have 
demonstrated that in atherosclerosis, along with morphologic 
changes, the arterial walls stiffen (Mohiaddin et al 1989; 
Forbat et al 1998). Some evidence exists, however, that in 
the early stages of atherosclerosis, the accumulation of lipids 
makes the arterial wall more compliant before the occur-
rence of ﬁ  brosis (Lehmann et al 1992; Kupari et al 1994). 
Furthermore, Toikka et al (1999) saw no difference between 
arterial distensibility assessed with aortic MRI and carotid 
US of 10 asymptomatic FH patients and controls aged 34 
years on average.
We found positive correlations between PWV and BSA-
adjusted volume of the aortic wall. Correlations between 
these measures and compliance were negative, indicating 
that all our MRI parameters were consistent in measuring 
aortic properties (Table 5). The lumen did not narrow when 
Table 2 Morphologic and functional measures of aorta and left common carotid artery of FH-NK patients and controls
 FH-NK  n  = 39  Control n = 25  P value
Volume of aortic wall/BSA, mm3/m2 10  563  ± 1826  10 200 ± 1358  0.427
Volume of aortic lumen/BSA, mm3/m2 29  252  ± 6865  29 063 ± 5641  0.915
Pulse wave velocity, m/s  3.86 ± 0.85  3.87± 0.82  0.964
Compliance AA, %/mmHg  0.76 ± 0.39  0.64 ± 0.29  0.237
Compliance DA, %/mmHg  0.57 ± 0.21  0.47 ± 0.13  0.062
Left CCA IMT, mm  0.57 ± 0.13  0.48 ± 0.13  0.003
CCA strain, %  15.18 ± 6.92  12.95 ± 3.33  0.502
Values are mean (SD).
Abbreviations: FH-NK, familial hypercholesterolemia-North Karelia; BSA, body surface area; AA, ascending aorta; DA, descending aorta; CCA, common carotid artery; IMT, 
intima-media thickness.
Compliance = [(systolic area – diastolic area)/diastolic area * 100]/(systolic BP-diastolic BP). CCA strain = (systolic diameter of CCA – diastolic diameter of CCA)/diastolic 
diameter of CCA * 100.Vascular Health and Risk Management 2008:4(4) 927
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the wall became thicker and stiffer, which could be a sign of 
positive remodeling (Glagov et al 1987) in our symptomless 
and relatively young patients.
In our study, established risk factors for atherosclerosis 
correlated signiﬁ  cantly with almost all the aortic measures 
(Table 3). The compliance of the ascending aorta correlated 
with more risk factors than compliance of the descend-
ing aorta. As DA is smaller than AA and distends less, 
the change in area between systolic and diastolic images 
are more difﬁ  cult to quantify at the spatial resolution of 
1.2 mm * 1.2 mm.
Age and gender explained best the variation in aor-
tic measures in our study (Table 4) and in the literature 
(Li et al 2004).
The major limitation of our study is that we could not get 
an age- and sex-matched control group. Also, not all the FH 
patients received statin therapy. The wide age range and statin 
therapy was taken into account by using cholesterol-years 
score, a parameter that correlated signiﬁ  cantly with almost 
all aortic measures (Table 3). Secondly, we believe that the 
statin therapy would normalize the aortic MRI parameters 
of the FH group even further, since the young untreated FH 
patients represent a subgroup with increased cholesterol year 
score. Thirdly, age was found to be an independent explaining 
factor for the variation in aortic measures assessed with mul-
tiple regression analysis, a result only found in a group with 
a wide range of age. In this FH patient group with uniform 
NK mutation the aortic MRI parameters we used appeared 
less sensitive than carotid IMT in indicating subclinical ath-
erosclerosis. However, similar parameters are able to show 
morphologic and functional changes in aortic atherosclerosis 
(Chan et al 2001; Metafratzi et al 2002; Li et al 2004). Our 
data are in concordance with a study on Framingham Risk 
Strata which shows low correlation between aortic MRI 
and carotid IMT in detection of subclinical atherosclerosis 
(Kathiresan et al 2007).
In conclusion, using several MRI methods we studied aor-
tic properties in a group of young FH patients with a uniform 
FH-NK mutation. Morphologic and functional parameters 
were comparable between FH-NK patients and controls. The 
patients had increased carotid IMT in US, showed positive 
remodeling and a trend to decreased stiffness in the aortic 
MRI. Morphologic and functional MRI parameters correlated 
consistently with each other and with cholesterol burden, 
which accentuates the results. The improved care of cardio-
vascular risk factors may protect the aorta of FH patients. 
Another possible explanation for the lack of difference is 
that aortic MRI may be less sensitive in ﬁ  nding subclinical 
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atherosclerosis than carotid US. Larger studies are needed 
to conﬁ  rm these hypotheses and to obtain normal values for 
aortic morphology and function. The inﬂ  uence of age and 
gender on vascular properties was marked and should be 
taken into account in further studies.
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